Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1999 1
2001 2
2005 1
2006 1
2007 1
2008 2
2009 3
2010 2
2011 1
2012 2
2013 1
2014 1
2015 2
2017 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung-prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT.
Wurstbauer K, Kazil M, Meinschad M, Pinter R, De Vries C, Clemens P, Kreuter C, Hernler T, Hitzl W, Cerkl P, Künzler T, De Vries A. Wurstbauer K, et al. Radiat Oncol. 2022 Jul 7;17(1):120. doi: 10.1186/s13014-022-02083-6. Radiat Oncol. 2022. PMID: 35799182 Free PMC article.
A dosimetric comparison of IORT techniques in limited-stage breast cancer.
Nairz O, Deutschmann H, Kopp M, Wurstbauer K, Kametriser G, Fastner G, Merz F, Reitsamer R, Menzel C, Sedlmayer F. Nairz O, et al. Among authors: wurstbauer k. Strahlenther Onkol. 2006 Jun;182(6):342-8. doi: 10.1007/s00066-006-1580-2. Strahlenther Onkol. 2006. PMID: 16703290
DART-bid for loco-regionally advanced NSCLC : Summary of acute and late toxicity with long-term follow-up; experiences with pulmonary dose constraints.
Wurstbauer K, Zehentmayr F, Deutschmann H, Dagn K, Exeli AK, Kopp P, Porsch P, Maurer B, Studnicka M, Sedlmayer F. Wurstbauer K, et al. Strahlenther Onkol. 2017 Apr;193(4):315-323. doi: 10.1007/s00066-016-1095-4. Epub 2017 Jan 23. Strahlenther Onkol. 2017. PMID: 28116446 Free PMC article. Clinical Trial.
First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate.
Deutschmann H, Kametriser G, Steininger P, Scherer P, Schöller H, Gaisberger C, Mooslechner M, Mitterlechner B, Weichenberger H, Fastner G, Wurstbauer K, Jeschke S, Forstner R, Sedlmayer F. Deutschmann H, et al. Among authors: wurstbauer k. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1624-32. doi: 10.1016/j.ijrobp.2011.10.009. Epub 2011 Dec 30. Int J Radiat Oncol Biol Phys. 2012. PMID: 22209149
Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).
Zehentmayr F, Söhn M, Exeli AK, Wurstbauer K, Tröller A, Deutschmann H, Fastner G, Fussl C, Steininger P, Kranzinger M, Belka C, Studnicka M, Sedlmayer F. Zehentmayr F, et al. Among authors: wurstbauer k. Radiat Oncol. 2015 May 28;10:121. doi: 10.1186/s13014-015-0429-1. Radiat Oncol. 2015. PMID: 26018527 Free PMC article.
20 results